Zeni et al.[48] reported that the percentage of IL-10-positive macrophages within tumor islet was higher in patients with late stage of NSCLC having lymph node metastasis than those patients with early stage of NSCLC having no metastasis, and these macrophages also predicted the worse overall survival. The gene discussed is IL10; the disease is non-small cell lung carcinoma.